Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Takeda Brentuximab; Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-positive Lymphoma
Disc Medicine
Patients with stage II-IV high risk diffuse large B-cell lymphoma, defined as international prognostic index > 2, Lymphoma
1 trial -
Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Takeda
Healthy
1 trial -
Teduglutide
Takeda
Healthy Volunteers
1 trial -
Teduglutide
Takeda
Hepatic Impairment
1 trial -
Trebananib 3 mg/kg
Takeda
Neoplasms, Advanced Solid
1 trial -
VP 20629
Takeda
Friedreich's Ataxia
1 trial -
Vedolizumab SC
Takeda
Healthy
1 trial -
Vedolizumab SC
Takeda
Healthy Volunteers
4 trials -
Vortioxetine
Takeda
Healthy
1 trial -
Vortioxetine
Takeda
Healthy Adult Participants
1 trial -
Vortioxetine
Takeda
Severe Hepatic Impairment
1 trial -
Zasocitinib
Takeda
Healthy Volunteers
1 trial -
[14C] Subasumstat
Takeda
Solid Tumors
1 trial -
[14C]-TAK-385 Oral Solution
Takeda
Healthy Volunteers
1 trial -
[14C]-TAK-954
Takeda
Healthy Volunteers
1 trial -
[68Ga]MLN6907
Takeda
Imaging of Solid Gastrointestinal Tumors
1 trial -
[^14C]-alisertib
Takeda
Advanced Solid Tumors
1 trial -
alisertib
Takeda
Advanced Malignancies
2 trials -
alisertib
Takeda
Acinar Cell Adenocarcinoma of the Pancreas
1 trial -
eASC
Takeda
Localized Adverse Reaction to Administration of Drug
1 trial -
immediate release guanfacine hydrochloride
Takeda
Healthy Volunteers
1 trial -
lumbar puncture
Takeda
Crohn's Disease
1 trial -
namilumab (MT203)
Takeda
Rheumatoid Arthritis
1 trial -
placebo control
Takeda
Hemophilia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources